Black men younger than 56 years old were twice as likely as White men to experience more than 6 months delay in treatment of their localized prostate cancer. That’s the finding of an analysis of nearly 90,000 men diagnosed with prostate cancer from 2004 to 2017, in a study led by Bhav Jain of the Massachusetts Institute of Technology. The delay occurred even for Black men with private insurance or managed care.
See the abstract of the scientific paper “Racial disparities in treatment delay among younger men with prostate cancer” by Bhav Jain et al.
